Hey Ahab, I still visit this site. Hard to get excited to post about BTX when the share price is down from $2.70 to $0.86 in the past 3 months. At this point, BTX is basically trading at liquidation value. The market cap of around $100mm is almost identical to the sum of their cash in the bank, promissory note from Juvenescence, and OCX/AGE/AST holdings. That assigns exactly zero value to BTX's entire pipeline and IP. If we look forward to BTX in a post BTX/AST merger world, it boosts the market cap to a whopping $120mm, with about $20mm assigned to both BTX and AST's pipelines and IP combined. I know the biotech and overall markets are down hard here, but this is the kind of level I would have expected from BTX at the bottom of a 60% market crash, not a 20% drop. At this point, I figure either Friday's lifetime record high trading volume was either seller capitulation, or BTX is somehow criminal (I have no reason to think this, so I am assuming once the panic subsides, BTX will rise above a dollar fairly quickly, and then we will see what it has in the tank.) I am thinking the cessation of tax loss selling/market crashing combined with BTX's "aggressive rollout of plans" at the JP Morgan Healthcare Conference the week of January 7th - January 10th might give BTX a chance to reverse its relentless decline in the next few weeks. Either that, or at this pace, the stock will be at zero by the end of January!
News 
Market Data 
Discover 
